A detailed history of Artemis Investment Management LLP transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Artemis Investment Management LLP holds 295,530 shares of RDY stock, worth $4.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
295,530
Previous 59,306 398.31%
Holding current value
$4.4 Million
Previous $4.71 Million 0.96%
% of portfolio
0.07%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$13.99 - $79.75 $3.3 Million - $18.8 Million
236,224 Added 398.31%
295,530 $4.67 Million
Q3 2024

Oct 08, 2024

BUY
$75.41 - $84.21 $3.3 Million - $3.68 Million
43,706 Added 280.17%
59,306 $4.71 Million
Q2 2024

Jul 15, 2024

BUY
$68.26 - $76.19 $511,950 - $571,425
7,500 Added 92.59%
15,600 $1.19 Million
Q1 2024

Apr 16, 2024

BUY
$67.36 - $77.59 $545,616 - $628,479
8,100 New
8,100 $594,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.47B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.